Journal
MOLECULAR IMAGING
Volume 11, Issue 3, Pages 187-196Publisher
SAGE PUBLICATIONS INC
DOI: 10.2310/7290.2011.00039
Keywords
-
Funding
- Arizona Cancer Center [NIH CA023074]
- NIH [NHLBI R01-HL090716, NIBIB P41-EB002035]
- Walther Cancer Foundation
Ask authors/readers for more resources
A fluorescent zinc 2,2'-dipicolylamine coordination complex PSVue (R) 794 (probe 1) is known to selectively bind to phosphatidylserine exposed on the surface of apoptotic and necrotic cells. In this study, we investigated the cell death targeting properties of probe 1 in myocardial ischemia-reperfusion injury. A rat heart model of ischemia-reperfusion was used. Probe 1, control dye, or Tc-99m glucarate was intravenously injected in rats subjected to 30-minute and 5-minute myocardial ischemia followed by 2-hour reperfusion. At 90 minutes or 20 hours postinjection, myocardial uptake was evaluated ex vivo by fluorescence imaging and autoradiography. Hematoxylin-eosin and cleaved caspase-3 staining was performed on myocardial sections to demonstrate the presence of ischemia-reperfusion injury and apoptosis. Selective accumulation of probe 1 could be detected in the area at risk up to 20 hours postinjection. Similar topography and extent of uptake of probe 1 and Tc-99m glucarate were observed at 90 minutes postinjection. Histologic analysis demonstrated the presence of necrosis, but only a few apoptotic cells could be detected. Probe 1 selectively accumulates in myocardial ischemia-reperfusion injury and is a promising cell death imaging tool.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available